NAMLG lunch meeting to be held in Sponsor Meeting Hub (in Hall 9) between 11:30 and 13:30 on Saturday 15th June.

Preliminary agenda

• 11:30-11:35: Welcome, v. Bjørn-Tore Gjertsen, Chairman
• 11:35-11:45 Remarks from the sponsor v. Delbert Pharma
• 11:45-12:25: NAMLG activities:
  • 11:45-11:55: Scientific working group, Sören Lehmann
  • 11:55-12:05: Educational working group, Albin Österroos/Daniel Tuyet Kristensen
  • 12:05-12:25: Trial working group, Bjørn Tore Gjertsen
    • Drug repurposing trials in RR AML: Melphalan for hypoplastic AML / DDX41 mutated (Jakob Dalgaard)
    • HUVAMER and Early response evaluation (Bjørn Tore Gjertsen)

• 12:25-12:55: Diagnostic working group, Linda Fogelstrand
• 12:55-13:05: About the 2025 biannual NAMLG meeting, Björn Tore Gjertsen
• 13:05-13:10: Steering group meeting schedule for 2024/2025, Daniel Tuyet Kristensen
• 13:10-13:30: Any other business and mingle with colleagues

For the Teams link, please contact Daniel (dakr@dcm.aau.dk) or Albin (albin.osterroos@medsci.uu.se).

Please, find more info at Invitation letter – NAMLG lunch – Madrid 2024.